Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation"

J Oncol. 2020 Mar 31:2020:8947367. doi: 10.1155/2020/8947367. eCollection 2020.

D Brocco¹, P Lanuti^{2

3}, P Simeone^{2

3}, G Bologna^{2

3}, D Pieragostino^{3

4}, M C Cufaro^{3

4}, V Graziano^{5

6}, M Peri¹, P Di Marino¹, M De Tursi⁶, A Grassadonia⁶, I G Rapposelli⁷, L Pierdomenico^{2

3}, E Ercolino^{2

3}, F Ciccocioppo^{2

3}, P Del Boccio^{3

8}, M Marchisio^{2

3}, C Natoli⁶, S Miscia^{2

3}, N Tinari⁶

¹ Clinical Oncology Unit, SS Annunziata Hospital, Chieti, Italy.
² Department of Medicine and Aging Sciences, University "G. D'Annunzio" of Chieti-Pescara, Chieti, Italy.
³ Centre on Aging Sciences and Translational Medicine (Ce. S. I.-Me. T.), University "G. D'Annunzio" of Chieti- Pescara, Chieti, Italy.
⁴ Department of Medical, Oral and Biotechnological Sciences, University "G. D'Annunzio" of Chieti-Pescara, Analytical Biochemistry and Proteomics Laboratory, Chieti, Italy.
⁵ Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
⁶ Department of Medical, Oral and Biotechnological Sciences, Gabriele D'Annunzio University, Chieti, Italy.
⁷ Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
⁸ Department of Pharmacy, University "G. D'Annunzio" of Chieti-Pescara, Chieti, Italy.

Abstract

[This corrects the article DOI: 10.1155/2019/5879616.].